216 related articles for article (PubMed ID: 31117740)
1. Nanoscale Lipophilic Prodrugs of Dexamethasone with Enhanced Pharmacokinetics.
Lorscheider M; Tsapis N; Simón-Vázquez R; Guiblin N; Ghermani N; Reynaud F; Canioni R; Abreu S; Chaminade P; Fattal E
Mol Pharm; 2019 Jul; 16(7):2999-3010. PubMed ID: 31117740
[TBL] [Abstract][Full Text] [Related]
2. Improving dexamethasone drug loading and efficacy in treating arthritis through a lipophilic prodrug entrapped into PLGA-PEG nanoparticles.
Simón-Vázquez R; Tsapis N; Lorscheider M; Rodríguez A; Calleja P; Mousnier L; de Miguel Villegas E; González-Fernández Á; Fattal E
Drug Deliv Transl Res; 2022 May; 12(5):1270-1284. PubMed ID: 34993924
[TBL] [Abstract][Full Text] [Related]
3. Modulation of release and pharmacokinetics from nanoscale lipid prodrugs of dexamethasone with variable linkage chemistry.
Ur-Rehman M; Reynaud F; Lepetre S; Abreu S; Chaminade P; Fattal E; Tsapis N
J Control Release; 2023 Aug; 360():293-303. PubMed ID: 37391032
[TBL] [Abstract][Full Text] [Related]
4. Dexamethasone palmitate large porous particles: A controlled release formulation for lung delivery of corticosteroids.
N'Guessan A; Fattal E; Chapron D; Gueutin C; Koffi A; Tsapis N
Eur J Pharm Sci; 2018 Feb; 113():185-192. PubMed ID: 28890202
[TBL] [Abstract][Full Text] [Related]
5. Mannosylation of budesonide palmitate nanoprodrugs for improved macrophage targeting.
Pinheiro do Nascimento L; Tsapis N; Reynaud F; Desmaële D; Moine L; Vergnaud J; Abreu S; Chaminade P; Fattal E
Eur J Pharm Biopharm; 2022 Jan; 170():112-120. PubMed ID: 34890789
[TBL] [Abstract][Full Text] [Related]
6. Development and in vitro evaluation of core-shell type lipid-polymer hybrid nanoparticles for the delivery of erlotinib in non-small cell lung cancer.
Mandal B; Mittal NK; Balabathula P; Thoma LA; Wood GC
Eur J Pharm Sci; 2016 Jan; 81():162-71. PubMed ID: 26517962
[TBL] [Abstract][Full Text] [Related]
7. Optimization of Weight Ratio for DSPE-PEG/TPGS Hybrid Micelles to Improve Drug Retention and Tumor Penetration.
Jin Y; Wu Z; Li C; Zhou W; Shaw JP; Baguley BC; Liu J; Zhang W
Pharm Res; 2018 Jan; 35(1):13. PubMed ID: 29302821
[TBL] [Abstract][Full Text] [Related]
8. Lipid-polymer hybrid nanoparticles as a new generation therapeutic delivery platform: a review.
Hadinoto K; Sundaresan A; Cheow WS
Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt A):427-43. PubMed ID: 23872180
[TBL] [Abstract][Full Text] [Related]
9. Dexamethasone palmitate nanoparticles: An efficient treatment for rheumatoid arthritis.
Lorscheider M; Tsapis N; Ur-Rehman M; Gaudin F; Stolfa I; Abreu S; Mura S; Chaminade P; Espeli M; Fattal E
J Control Release; 2019 Feb; 296():179-189. PubMed ID: 30659904
[TBL] [Abstract][Full Text] [Related]
10. Folate-modified lipid-polymer hybrid nanoparticles for targeted paclitaxel delivery.
Zhang L; Zhu D; Dong X; Sun H; Song C; Wang C; Kong D
Int J Nanomedicine; 2015; 10():2101-14. PubMed ID: 25844039
[TBL] [Abstract][Full Text] [Related]
11. Poly(ethylene glycol)-block-poly(ε-caprolactone)-and phospholipid-based stealth nanoparticles with enhanced therapeutic efficacy on murine breast cancer by improved intracellular drug delivery.
He X; Li L; Su H; Zhou D; Song H; Wang L; Jiang X
Int J Nanomedicine; 2015; 10():1791-804. PubMed ID: 25784805
[TBL] [Abstract][Full Text] [Related]
12. Quantitative and high drug loading of self-assembled prodrug with defined molecular structures for effective cancer therapy.
Tang J; Zeng Z; Yan J; Chen C; Liu J; Feng X
J Control Release; 2019 Aug; 307():90-97. PubMed ID: 31185233
[TBL] [Abstract][Full Text] [Related]
13. Modular Acid-Activatable Acetone-Based Ketal-Linked Nanomedicine by Dexamethasone Prodrugs for Enhanced Anti-Rheumatoid Arthritis with Low Side Effects.
Xu Y; Mu J; Xu Z; Zhong H; Chen Z; Ni Q; Liang XJ; Guo S
Nano Lett; 2020 Apr; 20(4):2558-2568. PubMed ID: 32167768
[TBL] [Abstract][Full Text] [Related]
14. Formulation optimization of an ephrin A2 targeted immunoliposome encapsulating reversibly modified taxane prodrugs.
Huang ZR; Tipparaju SK; Kirpotin DB; Pien C; Kornaga T; Noble CO; Koshkaryev A; Tran J; Kamoun WS; Drummond DC
J Control Release; 2019 Sep; 310():47-57. PubMed ID: 31400383
[TBL] [Abstract][Full Text] [Related]
15. Cation instructed steroidal prodrug supramolecular hydrogel.
Zhou Y; Lei L; Zhang Z; Zhang R; Song Q; Li X
J Colloid Interface Sci; 2018 Oct; 528():10-17. PubMed ID: 29803956
[TBL] [Abstract][Full Text] [Related]
16. Design and in vitro evaluation of biocompatible dexamethasone-loaded nanoparticle dispersions, obtained from nano-emulsions, for inhalatory therapy.
Fornaguera C; Llinàs M; Solans C; Calderó G
Colloids Surf B Biointerfaces; 2015 Jan; 125():58-64. PubMed ID: 25437064
[TBL] [Abstract][Full Text] [Related]
17. A preliminary evaluation of dexamethasone palmitate emulsion: a novel intravitreal sustained delivery of corticosteroid for treatment of macular edema.
Daull P; Paterson CA; Kuppermann BD; Garrigue JS
J Ocul Pharmacol Ther; 2013 Mar; 29(2):258-69. PubMed ID: 23331052
[TBL] [Abstract][Full Text] [Related]
18. PEGylated solid lipid nanoparticles for brain delivery of lipophilic kiteplatin Pt(IV) prodrugs: An in vitro study.
Arduino I; Depalo N; Re F; Dal Magro R; Panniello A; Margiotta N; Fanizza E; Lopalco A; Laquintana V; Cutrignelli A; Lopedota AA; Franco M; Denora N
Int J Pharm; 2020 Jun; 583():119351. PubMed ID: 32339634
[TBL] [Abstract][Full Text] [Related]
19. Nanoparticle-based topical ophthalmic formulation for sustained release of stereoisomeric dipeptide prodrugs of ganciclovir.
Yang X; Shah SJ; Wang Z; Agrahari V; Pal D; Mitra AK
Drug Deliv; 2016 Sep; 23(7):2399-2409. PubMed ID: 25564964
[TBL] [Abstract][Full Text] [Related]
20. Nanoparticles Containing High Loads of Paclitaxel-Silicate Prodrugs: Formulation, Drug Release, and Anticancer Efficacy.
Han J; Michel AR; Lee HS; Kalscheuer S; Wohl A; Hoye TR; McCormick AV; Panyam J; Macosko CW
Mol Pharm; 2015 Dec; 12(12):4329-35. PubMed ID: 26505116
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
